Treatment Strategies for B-Cell Acute Lymphoblastic Leukemia in Younger Patients
B-cell ALL accounting for most childhood cases.
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy, with B-cell ALL accounting for most childhood cases.
This establishes that the discussion is centered on B‑cell ALL, the predominant type of childhood leukemia.
Evidence level: Megerősített klinikai bizonyíték. Több vagy erősebb humán vizsgálat támogatja.
Related signals
- Acute Myeloid Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
- Recent advances on blinatumomab for acute lymphoblastic leukemia
- NCT05800210: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
- Advancing the Diagnosis of Non‑Hodgkin Lymphoma Through Next‑Generation Sequencing in Developing Countries: An Evaluation of Progress — A Narrative Review
- The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia